Diabetes 46: 785-791, 1997
Ernie Blevins, an endocrinologist at the University of Washington, and his colleagues co-administered oxytocin and a low dose of tirzepatide, a dual agonist mimicking the effects of both GLP-1 and glucose-dependent insulinotropic polypeptide, to obese rats and discovered that together, they produced more pronounced weight loss than either treatment alone
[65] indicated elevated blood homocysteine levels in individuals with Type 2 diabetes mellitus (T2DM), particularly among those with diabetic nephropathy (DN) and diabetic retinopathy (DR), but the precise role of homocysteine in the development of T2DM and its associated complications remains ambiguous
When you're losing weight on GLP-1s, you want that weight loss to be fat, not muscle
Hormonal optimization cha